Palbociclib TCI P3315

Chemical Identity

CAS No.: 571190-30-2
Purity: >97.0%(HPLC)(T)

Rp 1.565.550,00

Sale Sold out

Shipping calculated at checkout.

Berat 200mg 1g

Pembayaran hanya melalui request quotation dan dilakukan setelah tim kami menghubungi Anda. Mohon cantumkan nomor WhatsApp aktif untuk konfirmasi pesanan & pembuatan invoice. Estimasi pengiriman 2-4 minggu setelah pembayaran.

Dokumen Keamanan & Mutu

↓ Unduh SDS / MSDS (PDF resmi TCI)

CoA (Certificate of Analysis)

Spesifik per batch produksi — diterbitkan dan dikirim bersama barang sesuai nomor lot yang Anda terima.

Contoh CoA segera tersedia.

💬 Minta CoA via WhatsApp

View full details

Palbociclib is a chemical compound widely used in pharmacological and biochemical research for the development of cancer therapies. As a CDK4/6 inhibitor, it plays a crucial role in suppressing the uncontrolled growth of cancer cells by interfering with key cell cycle regulatory pathways. This compound is essential for researchers aiming to understand the molecular mechanisms underlying cancer progression and to evaluate potential therapeutic interventions. Its application extends beyond basic research, supporting the development of targeted therapies that improve patient outcomes in oncology.

Palbociclib is favored for its chemical stability and compatibility with various analytical techniques such as spectroscopy and chromatography. Its well-defined chemical properties make it a reliable reagent for experimental consistency and reproducibility. The compound’s solid form facilitates accurate weighing and handling, ensuring precision in laboratory procedures. Additionally, its specificity allows for targeted studies, making it a preferred choice in both academic and industrial research settings.

In Indonesian laboratories, Palbociclib is commonly used by researchers and scientists in the field of oncology. It supports studies focused on the prevention and treatment of cancer, particularly in local research initiatives aimed at developing more effective therapeutic strategies. Its presence in the laboratory environment enables scientists to conduct experiments that contribute to the broader understanding of cancer biology and drug development.

TCI brochures (PDF)

Pharmaceutical Ingredients for Research and Experimental Use 2026-03-09 · p. 19

Related TCI products

Cancer research applications benefit from Palbociclib’s ability to inhibit CDK4/6, making it ideal for studying cell cycle regulation in tumor cells.
Pharmaceutical research uses Palbociclib to evaluate the efficacy and mechanism of action of potential anti-cancer drugs in preclinical trials.
Biochemical experiments rely on Palbociclib for its stability and compatibility with analytical methods such as HPLC and mass spectrometry.
Drug development projects incorporate Palbociclib to assess the impact of CDK4/6 inhibition on cancer cell proliferation and survival.
Clinical research studies utilize Palbociclib to explore its therapeutic potential in human cancer models and to understand treatment responses.

Brand	TCI
CAS number	571190-30-2
Molecular formula	—
Purity	—
Category	Life Science > Biochemicals and Reagents > Pharmaceutical Research Reagents
Pack sizes	As listed on product page
Physical form	Solid
Storage	Store in a cool, dry place away from light

Palbociclib should be stored in a cool, dry environment to maintain its chemical stability and prevent degradation. It is recommended to keep the compound in a tightly sealed container to minimize exposure to moisture and air. Due to its solid form, it is easy to handle and accurately measure for experimental use. Laboratory personnel should ensure proper ventilation when working with the compound to avoid inhalation of any airborne particles. It is important to follow standard safety protocols when handling chemical reagents, including the use of personal protective equipment such as gloves and safety goggles. Proper storage and handling practices help ensure the integrity of the compound and the safety of laboratory staff.

—